亲环素 A 非依赖性 NS5A 和 NS5B 招募进入丙型肝炎病毒复制复合物。
Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.
机构信息
Department of Immunology & Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
出版信息
J Gen Virol. 2010 May;91(Pt 5):1189-93. doi: 10.1099/vir.0.018531-0. Epub 2010 Jan 27.
Abstract
The mechanisms by which cyclophilin A (CypA) governs hepatitis C virus (HCV) replication remain unknown. Since CypA binds two essential components of the HCV replication complex (RC)--the polymerase NS5B and the phosphoprotein NS5A--we asked in this study whether CypA regulates their RC association. We found that CypA, via its isomerase pocket, locates in a protease-resistant compartment similar to that where HCV replicates. CypA association with this compartment is not mediated by HCV. Moreover, CypA depletion of RC does not influence NS5A and NS5B RC association, arguing against a model where CypA governs HCV replication by recruiting NS5A or NS5B into RC.
摘要
亲环素 A (CypA) 调控丙型肝炎病毒 (HCV) 复制的机制尚不清楚。由于 CypA 结合了 HCV 复制复合物 (RC) 的两个必需成分——聚合酶 NS5B 和磷酸蛋白 NS5A——我们在这项研究中询问 CypA 是否调节它们的 RC 结合。我们发现 CypA 通过其异构酶口袋定位于类似于 HCV 复制的蛋白酶抗性隔室。CypA 与该隔室的结合不是由 HCV 介导的。此外，CypA 耗尽 RC 并不影响 NS5A 和 NS5B RC 结合，这排除了 CypA 通过将 NS5A 或 NS5B 募集到 RC 中来调控 HCV 复制的模型。
相似文献
1
Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes.
J Gen Virol. 2010 May;91(Pt 5):1189-93. doi: 10.1099/vir.0.018531-0. Epub 2010 Jan 27.
2
Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex.
J Virol. 2009 Jul;83(13):6554-65. doi: 10.1128/JVI.02550-08. Epub 2009 Apr 22.
3
Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.
J Biol Chem. 2012 Dec 28;287(53):44249-60. doi: 10.1074/jbc.M112.392209. Epub 2012 Nov 14.
4
ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
J Virol. 2020 Sep 29;94(20). doi: 10.1128/JVI.00532-20.
5
The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
J Virol Methods. 2010 May;165(2):202-10. doi: 10.1016/j.jviromet.2010.01.020. Epub 2010 Feb 2.
6
Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.
J Virol. 2016 Sep 29;90(20):9075-95. doi: 10.1128/JVI.00960-16. Print 2016 Oct 15.
7
The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
Antimicrob Agents Chemother. 2012 Jul;56(7):3888-97. doi: 10.1128/AAC.00693-12. Epub 2012 May 14.
8
The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.
J Biol Chem. 2009 Jun 19;284(25):16998-17005. doi: 10.1074/jbc.M109.007625. Epub 2009 Apr 20.
9
HCV NS5A and IRF9 compete for CypA binding.
J Hepatol. 2013 Jan;58(1):16-23. doi: 10.1016/j.jhep.2012.08.007. Epub 2012 Aug 15.
10
Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.
ACS Infect Dis. 2016 Nov 11;2(11):839-851. doi: 10.1021/acsinfecdis.6b00143. Epub 2016 Oct 5.
引用本文的文献
1
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections.
Viruses. 2024 Dec 25;17(1):11. doi: 10.3390/v17010011.
2
Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities.
Biology (Basel). 2023 Jul 14;12(7):1008. doi: 10.3390/biology12071008.
3
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
J Virol. 2021 Jul 12;95(15):e0056321. doi: 10.1128/JVI.00563-21.
4
Host-Directed Antiviral Therapy.
Clin Microbiol Rev. 2020 May 13;33(3). doi: 10.1128/CMR.00168-19. Print 2020 Jun 17.
5
Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus.
Elife. 2019 May 10;8:e44436. doi: 10.7554/eLife.44436.
6
Cyclophilin A as a target in the treatment of cytomegalovirus infections.
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618811413. doi: 10.1177/2040206618811413.
7
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00126-18. Print 2018 Jul.
8
Chaperones in hepatitis C virus infection.
World J Hepatol. 2016 Jan 8;8(1):9-35. doi: 10.4254/wjh.v8.i1.9.
9
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection.
Hepatol Int. 2016 Mar;10(2):258-66. doi: 10.1007/s12072-015-9668-3. Epub 2015 Nov 5.
10
Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factories.
Antimicrob Agents Chemother. 2015 May;59(5):2496-507. doi: 10.1128/AAC.04958-14. Epub 2015 Feb 9.
本文引用的文献
1
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
J Hepatol. 2010 Jul;53(1):50-6. doi: 10.1016/j.jhep.2010.01.041. Epub 2010 Apr 3.
2
The potent antimalarial drug cyclosporin A preferentially destabilizes sphingomyelin-rich membranes.
Langmuir. 2010 Feb 2;26(3):1960-5. doi: 10.1021/la902580w.
3
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
PLoS Pathog. 2009 Aug;5(8):e1000546. doi: 10.1371/journal.ppat.1000546. Epub 2009 Aug 14.
4
Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.
Cancer Sci. 2009 Oct;100(10):1943-50. doi: 10.1111/j.1349-7006.2009.01263.x. Epub 2009 Jun 26.
5
Cyclophilin inhibitors.
Clin Liver Dis. 2009 Aug;13(3):403-17. doi: 10.1016/j.cld.2009.05.002.
6
Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex.
J Virol. 2009 Jul;83(13):6554-65. doi: 10.1128/JVI.02550-08. Epub 2009 Apr 22.
7
The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.
J Biol Chem. 2009 Jun 19;284(25):16998-17005. doi: 10.1074/jbc.M109.007625. Epub 2009 Apr 20.
8
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.
Hepatology. 2009 May;49(5):1460-8. doi: 10.1002/hep.22835.
9
Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B.
J Biol Chem. 2009 May 15;284(20):13589-13601. doi: 10.1074/jbc.M809244200. Epub 2009 Mar 18.
10
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors.
Antimicrob Agents Chemother. 2009 Mar;53(3):967-76. doi: 10.1128/AAC.00939-08. Epub 2008 Dec 22.
Zotero 插件